Anemia Management

The presentation discusses the state of the science related to anemia as a silent pandemic, including diagnosis, treatment, and patient impact.

Lecture Presenters
Image
Carolyn Burns, MD
Carolyn Burns, MD
CMO and Cofounder, Collaborative Clinical Consulting, LLC
Immediate Past President, Society for the Advancement of Patient Blood Management (SABM)

Carolyn Burns, MD, is a board-certified pathologist (AP/CP) and served as medical director and chief of pathology at the Jewish Hospital Healthcare System, in Louisville, Kentucky, from 1991-2011. This included medical directorships of surgical pathology, clinical laboratory, and the transfusion/tissue services for this five-hospital system. She has previously been an assistant clinical professor in the Department of Pathology at the University of Louisville and was on the advisory board and a guest lecturer for the Bellarmine University Clinical Laboratory Science Program.

After earning her microbiology undergraduate degree and her subsequent medical degree, Dr. Burns completed an internship in general surgery followed by a pathology residency at the University of Louisville. Dr. Burns is the current immediate past president for the Society for the Advancement of Patient Blood Management (SABM).

Dr. Burns is an active member of several medical societies, including AABB and IARS. She has numerous publications in peer-reviewed journals and textbooks and is often sought after as an engaging speaker, both nationally and internationally, regarding patient blood management (PBM) and transfusion practices.

Dr. Burns is a PBM physician advisor/consultant working with numerous hospitals and systems throughout the U.S. She is the CMO and cofounder of Collaborative Clinical Consulting, a company providing PBM education, implementation services, and perioperative assessment.

Image
Katherine DiPalo, PharmD
Katherine DiPalo, PharmD
Assistant Professor, Department of Medicine, Albert Einstein College of Medicine

Katherine Di Palo, PharmD, is the senior director of Transitional Care Excellence at Montefiore Medical Center and an assistant professor of medicine at Albert Einstein College of Medicine in New York City. She is responsible for performance and quality improvement in value-based care initiatives and leads a multidisciplinary, multispecialty team that provides comprehensive, patient-centered care from hospital to home.

Dr. Di Palo received her doctorate of pharmacy from the University at Buffalo, trained in pharmacotherapy at the James J. Peters VA Medical Center in the Bronx, New York, and is board certified in ambulatory care and geriatrics. She received her MBA and MS in Health Care Policy and Research from Cornell University. Her research focuses on medication optimization and pharmacoequity among persons with cardiovascular-kidney-metabolic syndrome with active funding from the National Institutes of Health (NIH) and Patient-Centered Outcomes Research Institute (PCORI).

Objectives

After this presentation, participants will be able to:

Discuss factors leading to anemia in general patient populations as well as improved strategies other than only red blood cell transfusion
Understand anemia and iron deficiency as potentially separate entities as independent risk factors for morbidity
Discuss the uses, benefits, and downsides of oral and IV iron supplementation, using patients with heart failure as the primary example
Discuss the relevant literature surrounding oral and IV iron supplementation, using patients with heart failure as the primary example